The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen
Research Funding - Gilead Sciences; Roche
Prognostic role of beta-2 microglobulin (B2M) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) patients (pts) treated with ibrutinib (ibr).
 
William G. Wierda
Consulting or Advisory Role - Abbvie; Celgene; Emergent BioSolutions; Genentech/Roche; Genzyme; Gilead Sciences; GlaxoSmithKline/Novartis; Merck; Pharmacyclics; Sanofi
Research Funding - Abbvie; Acerta Pharma; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences
 
Stephan Stilgenbauer
Honoraria - AbbVie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche
Consulting or Advisory Role - AbbVie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche
Speakers' Bureau - AbbVie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche
Research Funding - Abbvie; Janssen; Pharmacyclics
Travel, Accommodations, Expenses - Abbvie; Janssen; Pharmacyclics
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Novartis (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
Anthony R. Mato
Honoraria - Medscape; PrIME Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Johnson & Johnson; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Acerta Pharma; Pharmacyclics; Portola Pharmaceuticals; Regeneron; TG Therapeutics
 
Constantine Tam
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Research Funding - Janssen
 
Jacqueline C. Barrientos
Consulting or Advisory Role - Abbvie/Pharmacyclics; Gilead Sciences; Janssen
Research Funding - Abbvie/Pharmacyclics (Inst); Gilead Sciences (Inst)
 
Ulrich Jäger
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Research Funding - Gilead Sciences (Inst); Novartis (Inst); Roche (Inst)
 
Stephen Devereux
Honoraria - Abbvie; Gilead Sciences; Janssen; MSD
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; MSD
Speakers' Bureau - Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Florence Cymbalista
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie
Research Funding - Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Roche
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Infinity Pharmaceuticals; Janssen; Novartis; Pharmacyclics; Seagen
Research Funding - Pharmacyclics (Inst)
 
Claire Dearden
Honoraria - AbbVie; Gilead Sciences; Janssen; Roche; Sanofi
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Roche; Sanofi
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Marco Montillo
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Carol Moreno
No Relationships to Disclose
 
Emily Y. Liu
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Anita Szoke
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
James P. Dean
Employment - CTI; Pharmacyclics
Stock and Other Ownership Interests - Abbvie; CTI
 
Susan Mary O'Brien
Employment - University of California, Irvine
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Eisai; Gilead Sciences; GlaxoSmithKline; Janssen; Loxo; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Alexion Pharmaceuticals; Amgen; Amgen Astellas BioPharma; Aptose Biosciences; Celgene; CLL Global Research Foundation; Eisai; GlaxoSmithKline; Janssen Oncology; Loxo; Pharmacyclics; Sunesis Pharmaceuticals; Vaniam Group
Research Funding - Acerta Pharma; Gilead Sciences; Pfizer; Pharmacyclics; ProNAI; Regeneron; TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron